Security key
65343E108
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)
CUSIP: 65343E108
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 20,244,521
- Total 13F value
- $434,046,210
- Share change
- +44,782
- Put/Call ratio
- 298%
- SEC-reported price per share
- $21.44
- Number of holders
- 87
- Value change
- -$4,189,870
- Number of buys
- 61
- Number of sells
- 30
- Shares outstanding
- 3,602,511
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
87
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E108
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 75%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 75%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
75%
Sofinnova Investments, Inc.
74%
LORD, ABBETT & CO. LLC
59%
Canaan Partners X LLC
56%
GREAT POINT PARTNERS LLC
36%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
75%
|
$100,497,000
2,711,013 shares
|
— | 31 Mar 2020 |
| Sofinnova Investments, Inc. |
13F
Company
|
74%
|
$99,046,000
2,671,856 shares
|
— | 31 Mar 2020 |
| LORD, ABBETT & CO. LLC |
13F
Company
|
59%
|
$79,231,000
2,137,346 shares
|
— | 31 Mar 2020 |
| Canaan Partners X LLC |
13F
Company
|
56%
|
$75,194,000
2,028,442 shares
|
— | 31 Mar 2020 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
36%
|
$48,671,000
1,312,956 shares
|
— | 31 Mar 2020 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
35%
|
$46,488,000
1,254,047 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
87
Shares
20,244,521
Rows available
87
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2020 holders
87
Holder diff
86
| Investor | Q3 2025 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend